Cargando…

Hypertension continuum of care: Blood pressure screening, diagnosis, treatment, and control in a population‐based cohort in Haiti

Cardiovascular disease (CVD) is the number one cause of death in low‐income countries including Haiti, with hypertension (HTN) being the leading risk factor. This study aims to identify gaps in the HTN continuum of screening, diagnosis, treatment, and blood pressure (BP) control. Sociodemographic an...

Descripción completa

Detalles Bibliográficos
Autores principales: Metz, Miranda, Pierre, Jean Lookens, Yan, Lily Du, Rouzier, Vanessa, St‐Preux, Stephano, Exantus, Serfine, Preval, Fabyola, Roberts, Nicholas, Tymejczyk, Olga, Malebranche, Rodolphe, Deschamps, Marie Marcelle, Pape, Jean W., McNairy, Margaret L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925011/
https://www.ncbi.nlm.nih.gov/pubmed/35199944
http://dx.doi.org/10.1111/jch.14399
_version_ 1784669977488392192
author Metz, Miranda
Pierre, Jean Lookens
Yan, Lily Du
Rouzier, Vanessa
St‐Preux, Stephano
Exantus, Serfine
Preval, Fabyola
Roberts, Nicholas
Tymejczyk, Olga
Malebranche, Rodolphe
Deschamps, Marie Marcelle
Pape, Jean W.
McNairy, Margaret L.
author_facet Metz, Miranda
Pierre, Jean Lookens
Yan, Lily Du
Rouzier, Vanessa
St‐Preux, Stephano
Exantus, Serfine
Preval, Fabyola
Roberts, Nicholas
Tymejczyk, Olga
Malebranche, Rodolphe
Deschamps, Marie Marcelle
Pape, Jean W.
McNairy, Margaret L.
author_sort Metz, Miranda
collection PubMed
description Cardiovascular disease (CVD) is the number one cause of death in low‐income countries including Haiti, with hypertension (HTN) being the leading risk factor. This study aims to identify gaps in the HTN continuum of screening, diagnosis, treatment, and blood pressure (BP) control. Sociodemographic and clinical data were collected from a population‐based sample of adults ≥18 years in Port‐au‐Prince (PAP) from March 2019 to April 2021. HTN was defined as systolic BP ≥ 140 mmHg, diastolic BP ≥ 90 mmHg, or use of antihypertensive medication. Screening was defined as ever having had a BP measurement; diagnosis as previously being informed of a HTN diagnosis; treatment as having taken antihypertensives in the past 2 weeks; and controlled as taking antihypertensives and having BP < 140/90 mmHg. Factors associated with attaining each step in the continuum were assessed using Poisson multivariable regressions. Among 2737 participants, 810 (29% age‐standardized) had HTN, of whom 97% had been screened, 72% diagnosed, 45% treated, and 13% controlled. There were no significant differences across age groups or sex. Obesity (BMI ≥ 30) was a significant factor associated with receiving treatment compared to normal weight (BMI < 25), with a prevalence ratio (PR) of 1.5 (95% CI 1.1–2.0). Having secondary or higher education was associated with higher likelihood of controlled BP (PR 1.9 [95% CI 1.1–3.3]). In this urban Haitian population, the greatest gaps in HTN care are treatment and control. Targeted interventions are needed to improve these steps, including broader access to affordable treatment, timely distribution of medications, and patient adherence to HTN medication.
format Online
Article
Text
id pubmed-8925011
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-89250112022-03-21 Hypertension continuum of care: Blood pressure screening, diagnosis, treatment, and control in a population‐based cohort in Haiti Metz, Miranda Pierre, Jean Lookens Yan, Lily Du Rouzier, Vanessa St‐Preux, Stephano Exantus, Serfine Preval, Fabyola Roberts, Nicholas Tymejczyk, Olga Malebranche, Rodolphe Deschamps, Marie Marcelle Pape, Jean W. McNairy, Margaret L. J Clin Hypertens (Greenwich) Epidemiology Cardiovascular disease (CVD) is the number one cause of death in low‐income countries including Haiti, with hypertension (HTN) being the leading risk factor. This study aims to identify gaps in the HTN continuum of screening, diagnosis, treatment, and blood pressure (BP) control. Sociodemographic and clinical data were collected from a population‐based sample of adults ≥18 years in Port‐au‐Prince (PAP) from March 2019 to April 2021. HTN was defined as systolic BP ≥ 140 mmHg, diastolic BP ≥ 90 mmHg, or use of antihypertensive medication. Screening was defined as ever having had a BP measurement; diagnosis as previously being informed of a HTN diagnosis; treatment as having taken antihypertensives in the past 2 weeks; and controlled as taking antihypertensives and having BP < 140/90 mmHg. Factors associated with attaining each step in the continuum were assessed using Poisson multivariable regressions. Among 2737 participants, 810 (29% age‐standardized) had HTN, of whom 97% had been screened, 72% diagnosed, 45% treated, and 13% controlled. There were no significant differences across age groups or sex. Obesity (BMI ≥ 30) was a significant factor associated with receiving treatment compared to normal weight (BMI < 25), with a prevalence ratio (PR) of 1.5 (95% CI 1.1–2.0). Having secondary or higher education was associated with higher likelihood of controlled BP (PR 1.9 [95% CI 1.1–3.3]). In this urban Haitian population, the greatest gaps in HTN care are treatment and control. Targeted interventions are needed to improve these steps, including broader access to affordable treatment, timely distribution of medications, and patient adherence to HTN medication. John Wiley and Sons Inc. 2022-02-24 /pmc/articles/PMC8925011/ /pubmed/35199944 http://dx.doi.org/10.1111/jch.14399 Text en © 2022 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals LLC https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Epidemiology
Metz, Miranda
Pierre, Jean Lookens
Yan, Lily Du
Rouzier, Vanessa
St‐Preux, Stephano
Exantus, Serfine
Preval, Fabyola
Roberts, Nicholas
Tymejczyk, Olga
Malebranche, Rodolphe
Deschamps, Marie Marcelle
Pape, Jean W.
McNairy, Margaret L.
Hypertension continuum of care: Blood pressure screening, diagnosis, treatment, and control in a population‐based cohort in Haiti
title Hypertension continuum of care: Blood pressure screening, diagnosis, treatment, and control in a population‐based cohort in Haiti
title_full Hypertension continuum of care: Blood pressure screening, diagnosis, treatment, and control in a population‐based cohort in Haiti
title_fullStr Hypertension continuum of care: Blood pressure screening, diagnosis, treatment, and control in a population‐based cohort in Haiti
title_full_unstemmed Hypertension continuum of care: Blood pressure screening, diagnosis, treatment, and control in a population‐based cohort in Haiti
title_short Hypertension continuum of care: Blood pressure screening, diagnosis, treatment, and control in a population‐based cohort in Haiti
title_sort hypertension continuum of care: blood pressure screening, diagnosis, treatment, and control in a population‐based cohort in haiti
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925011/
https://www.ncbi.nlm.nih.gov/pubmed/35199944
http://dx.doi.org/10.1111/jch.14399
work_keys_str_mv AT metzmiranda hypertensioncontinuumofcarebloodpressurescreeningdiagnosistreatmentandcontrolinapopulationbasedcohortinhaiti
AT pierrejeanlookens hypertensioncontinuumofcarebloodpressurescreeningdiagnosistreatmentandcontrolinapopulationbasedcohortinhaiti
AT yanlilydu hypertensioncontinuumofcarebloodpressurescreeningdiagnosistreatmentandcontrolinapopulationbasedcohortinhaiti
AT rouziervanessa hypertensioncontinuumofcarebloodpressurescreeningdiagnosistreatmentandcontrolinapopulationbasedcohortinhaiti
AT stpreuxstephano hypertensioncontinuumofcarebloodpressurescreeningdiagnosistreatmentandcontrolinapopulationbasedcohortinhaiti
AT exantusserfine hypertensioncontinuumofcarebloodpressurescreeningdiagnosistreatmentandcontrolinapopulationbasedcohortinhaiti
AT prevalfabyola hypertensioncontinuumofcarebloodpressurescreeningdiagnosistreatmentandcontrolinapopulationbasedcohortinhaiti
AT robertsnicholas hypertensioncontinuumofcarebloodpressurescreeningdiagnosistreatmentandcontrolinapopulationbasedcohortinhaiti
AT tymejczykolga hypertensioncontinuumofcarebloodpressurescreeningdiagnosistreatmentandcontrolinapopulationbasedcohortinhaiti
AT malebrancherodolphe hypertensioncontinuumofcarebloodpressurescreeningdiagnosistreatmentandcontrolinapopulationbasedcohortinhaiti
AT deschampsmariemarcelle hypertensioncontinuumofcarebloodpressurescreeningdiagnosistreatmentandcontrolinapopulationbasedcohortinhaiti
AT papejeanw hypertensioncontinuumofcarebloodpressurescreeningdiagnosistreatmentandcontrolinapopulationbasedcohortinhaiti
AT mcnairymargaretl hypertensioncontinuumofcarebloodpressurescreeningdiagnosistreatmentandcontrolinapopulationbasedcohortinhaiti